Larkspur Health Acquisiti... (LSPR)
NASDAQ: LSPR
· Real-Time Price · USD
22.50
12.83 (132.68%)
At close: Dec 13, 2022, 6:00 AM
Larkspur Health Acquisition Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -2.14B | -9.05B | -2.27B | -2.83B | -107.66B | -90.92M | -2.5M | 1.93M | -632K | -499K | -801K | -233K | -174 | -1.9K |
Interest Income | n/a | 109.57K | n/a | n/a | 109.57K | n/a | n/a | -110K | n/a | 105.11K | 4.45K | n/a | n/a | n/a |
Pretax Income | -2.26B | -9.33B | -2.4B | -2.83B | -106.16B | -82.06M | -4.59M | 925.18K | -632K | -394K | -720K | -239K | -174 | -1.9K |
Net Income | -2.26B | -9.33B | -2.4B | -2.83B | -106.16B | -82.06M | -3.54M | 1.42M | -679K | -183K | -635K | -244K | -174 | -1.9K |
Selling & General & Admin | 1.89B | 7.35B | 1.83B | 2.31B | 11.2B | 7.46M | 3.54M | 879.8K | n/a | 498.75K | 801.05K | 233.2K | 174.00 | 1.9K |
Research & Development | 258.88M | 1.78B | 436.04M | 512.94M | 3.2B | 2.28M | 1.06M | 400K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | -81.81M | n/a | n/a | 93.25B | 81.17M | n/a | n/a | -632K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.14B | 9.12B | 2.27B | 2.83B | 107.66B | 90.92M | 4.59M | 1.28M | -632K | 498.75K | 801.05K | 233.2K | 174.00 | 1.9K |
Interest Expense | 119.56M | 269.97M | 131.63M | 101K | -347K | n/a | n/a | -110K | n/a | 105.11K | 4.45K | 5.43K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 9.12B | n/a | n/a | 107.66B | 90.92M | 4.59M | 1.28M | -632K | 498.75K | 801.05K | 233.2K | 174.00 | 1.9K |
Income Tax Expense | n/a | -7.29M | n/a | n/a | -550K | n/a | 1.05M | -497K | 47.55K | -210K | -85.5K | 5.43K | n/a | n/a |
Shares Outstanding (Basic) | 31.07M | 11.1M | 988.38K | 623.6M | 975.03M | 8.09M | 8.09M | 8.09M | 8.09M | 10.03M | 10.01M | 10.01M | 10.01M | 2.09M |
Shares Outstanding (Diluted) | 31.07M | 11.1M | 988.38K | 623.6M | 975.03M | 8.09M | 8.09M | 8.09M | 8.09M | 10.03M | 10.01M | 10.01M | 10.01M | 2.09M |
EPS (Basic) | -0.73 | 1.93 | -2.43 | -4.53 | -98.56 | -10.15 | -0.44 | 0.18 | -0.08 | -0.02 | -0.06 | -0.02 | -0.00 | -0.00 |
EPS (Diluted) | -0.73 | 1.93 | -2.43 | -4.53 | -98.56 | -10.15 | -0.44 | 0.18 | -0.08 | -0.02 | -0.06 | -0.02 | -0.00 | -0.00 |
EBITDA | -2.14B | -9.07B | -2.27B | -2.83B | -106.16B | -90.92M | n/a | 519.89K | n/a | n/a | -716K | -239K | -174 | -1.9K |
EBIT | n/a | -816K | n/a | n/a | n/a | -90.92M | n/a | 815.61K | n/a | -289K | -716K | -233K | n/a | n/a |
Depreciation & Amortization | n/a | 132.05K | n/a | n/a | 295.72K | 122.08K | 41.58K | -296K | 27.08K | 210.23K | 85.5K | -5.43K | 54K | 55.81K |